Opportunities missed: Improving the rate of contraceptive counseling or provision when prescribing reproductive-aged women potentially teratogenic medications in a family medicine resident clinic

Contraception

Volumn 84, Issue 4, 2011, Pages 372-376

  Fritsche, Melissa D ^a   Ables, Adrienne Z ^a   Bendyk, Heather ^a  

^a Gibbs Cancer Center and Research Institute   (United States)

Author keywords

Contraceptive counseling; Education; Quality improvement; Teratogenic medications

Indexed keywords

BENZODIAZEPINE; DOXYCYCLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; MINOCYCLINE; PAROXETINE; TERATOGENIC AGENT; TETRACYCLINE; WARFARIN;

ADOLESCENT; ADULT; CONTRACEPTION; CONTRACEPTIVE COUNSELING; COUNSELING; ELECTRONIC MEDICAL RECORD; FAMILY MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; PATIENT COUNSELING; PATIENT EDUCATION; PRESCRIPTION; RESIDENCY EDUCATION; REVIEW;

EID: 80052820003     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.01.024     Document Type: Article

References (4)

1. Federal Register. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. 2008 May 29;73(104):30831-68.
2. Schwarz E.B., Maselli J., Norton M., and Gonzales R. Prescription of teratogenic medications in United States ambulatory practices Am J Med 118 2005 1240 1249 (Pubitemid 41566525)
3. Schwarz E.B., Postlewaite D.A., Hung Y.Y., and Armstrong M.A. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women Ann Intern Med 147 2007 370 376 (Pubitemid 351664537)
4. Gilchrist V.J., Stange K.C., Flocke S.A., McCord G., and Bourget C.C. A comparison of the National Ambulatory Medical Care Survey (NAMCS) measurement approach with direct observation of outpatient visits Med Care 42 2004 276 280